From the gut to the brain: the long journey of phenolic compounds with neurocognitive effects

dc.contributor.author
Domínguez López, Inés
dc.contributor.author
López Yerena, Anallely
dc.contributor.author
Vallverdú i Queralt, Anna
dc.contributor.author
Pallàs i Llibería, Mercè, 1964-
dc.contributor.author
Lamuela Raventós, Rosa Ma.
dc.contributor.author
Pérez Bosch, Maria
dc.date.issued
2024-10-31T10:53:33Z
dc.date.issued
2024-10-31T10:53:33Z
dc.date.issued
2024-04-30
dc.date.issued
2024-10-31T10:53:33Z
dc.identifier
0029-6643
dc.identifier
https://hdl.handle.net/2445/216152
dc.identifier
749044
dc.identifier
38687609
dc.description.abstract
The human gut microbiota is a complex community of microorganisms that play a crucial role in maintaining overall health. Recent research has shown that gut microbes also have a profound impact on brain function and cognition, leading to the concept of the gut-brain axis. One way in which the gut microbiota can influence the brain is through the bioconversion of polyphenols to other bioactive molecules. Phenolic compounds are a group of natural plant metabolites widely available in the human diet, which have anti-inflammatory and other positive effects on health. Recent studies have also suggested that some gut microbiota-derived phenolic metabolites may have neurocognitive effects, such as improving memory and cognitive function. The specific mechanisms involved are still being studied, but it is believed that phenolic metabolites may modulate neurotransmitter signalling, reduce inflammation, and enhance neural plasticity. Therefore, to exert a protective effect on neurocognition, dietary polyphenols or their metabolites must reach the brain, or act indirectly by producing an increase in bioactive molecules such as neurotransmitters. Once ingested, phenolic compounds are subjected to various processes (e.g., metabolization by gut microbiota, absorption, distribution) before they cross the blood-brain barrier (BBB), perhaps the most challenging stage of their trajectory. Understanding the role of phenolic compounds in the gut-brain axis has important implications for the development of new therapeutic strategies for neurological and psychiatric disorders. By targeting the gut microbiota and its production of phenolic metabolites, it may be possible to improve brain function and prevent cognitive decline. In this article, we review the current state of knowledge on the endogenous generation of phenolic metabolites by the gut microbiota and how these compounds can reach the brain and exert neurocognitive effects. 
dc.format
14 p.
dc.format
application/pdf
dc.format
application/pdf
dc.language
eng
dc.publisher
Oxford University Press
dc.relation
Reproducció del document publicat a: https://doi.org/10.1093/nutrit/nuae034
dc.relation
Nutrition Reviews, 2024
dc.relation
https://doi.org/10.1093/nutrit/nuae034
dc.rights
cc-by-nc-nd (c) Domínguez López et al., 2024
dc.rights
http://creativecommons.org/licenses/by-nc-nd/3.0/es/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Nutrició, Ciències de l'Alimentació i Gastronomia)
dc.subject
Polifenols
dc.subject
Microbiota intestinal
dc.subject
Malalties neurodegeneratives
dc.subject
Polyphenols
dc.subject
Gastrointestinal microbiome
dc.subject
Neurodegenerative Diseases
dc.title
From the gut to the brain: the long journey of phenolic compounds with neurocognitive effects
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Files in this item

FilesSizeFormatView

There are no files associated with this item.